MedTrace Logo

Gestrinone and Endothelial Function in Young Women

NCT06402344 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2025-03-11

No results posted yet for this study

Summary

The purpose of this study is to assess the association of hormonal implant with gestrinone in cardiovascular health outcomes in young women.

Conditions

Interventions

OTHER

Hormonal implant

History of at least 1 hormonal implant with gestrinone in the last 6 months, applied by the participant's private doctor.

OTHER

Control group

Young women who never used any hormonal implant.

Sponsors & Collaborators

  • Hospital Israelita Albert Einstein

    lead OTHER

Principal Investigators

  • Luciana Diniz Nagem Janot de Matos, MD, PhD · Medical Referencee - Rehabilitation Center

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-22
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06402344 on ClinicalTrials.gov